Latest Breaking News On - Sense therapeutics - Page 10 : comparemela.com

NeuroSense to Participate in Upcoming ALS Conferences: PACTALS in Malaysia and NEALS in the U S

NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, announced today it will participate in the following ALS conferences.

United statesKuala lumpurShiran zimriFerenc tracikAsian consortium for treatmentInternational panNeurosense therapeutics ltdInternational pan asian consortiumChief medicalAnnual northeast amyotrophic lateral sclerosisSense therapeuticsNeurodegenerative diseasesNternational pan asian consortium for treatment and researchFerenc tracikShiran zimriDisease progression

NeuroSense to Host Investor Webinar on September 12, 2023

Investors interested in meeting the executive team and hearing NeuroSense s strategy, updates, and upcoming catalysts are invited to register for the webinar event. CAMBRIDGE, Mass., Sept. 6, 2023.

United kingdomNedira salzmanShiran zimriFerenc tracikExchange commissionNeurosense therapeutics ltdNeurosense therapeuticsAlon ben noonChief medical officerAlzheimer diseaseSense therapeuticsNeurosense therapeuticAnnual report

NeuroSense Announces Second Quarter 2023 Financial Results and Provides Business Update

ALS Phase 2b PARADIGM Trial Completed Patient EnrollmentTopline results expected in Q-4 2023Cash runway beyond topline clinical study readouts, into Q-2 2024CAMBRIDGE, Mass., Aug. 16, 2023. -Today at 09:01 am- MarketScreener

United kingdomNeurosense therapeutics ltdPrnewswire neurosense therapeutics ltdExchange commissionCompleted patientSense therapeuticsAmyotrophic lateral sclerosisScientific agreementTrial underBiomarker studyBiomarkers summitMonths ended juneInterim unaudited statementsCash flowsNeurosense therapeuticAnnual report

NeuroSense Therapeutics (NASDAQ:NRSN) Earns Buy Rating from Analysts at Alliance Global Partners

NeuroSense Therapeutics (NASDAQ:NRSN) Earns Buy Rating from Analysts at Alliance Global Partners
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesNeurosense therapeutics company profileRenaissance technologiesMillennium managementNeurosense therapeutics ltdVanguard personalized indexing managementMeitav investment house ltdAlliance global partnersNeurosense therapeuticsFree reportSense therapeuticsGet free reportInvestment houseStreet groupPersonalized indexing managementSense therapeutics ltd

NeuroSense Therapeutics (NASDAQ:NRSN) Coverage Initiated at Alliance Global Partners

Stock analysts at Alliance Global Partners began coverage on shares of NeuroSense Therapeutics (NASDAQ:NRSN – Get Free Report) in a report issued on Monday, FlyOnTheWall reports. The brokerage set a “buy” rating on the stock. NeuroSense Therapeutics Trading Up 0.7 % NeuroSense Therapeutics stock opened at $1.39 on Monday. The stock has a 50-day moving […]

United statesNeurosense therapeutics ltdMillennium managementAlliance global partnersVanguard personalized indexing managementNeurosense therapeutics company profileNeurosense therapeuticsGet free reportSense therapeuticsMontreal canPersonalized indexing managementJane street groupSense therapeutics ltdNeurosense therapeutics dailyNasdaq nrsnInitiated coverage